间充质干细胞在移植物抗宿主病治疗与预防中的临床应用
Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease.
作者信息
Lin Yi, Hogan William J
机构信息
Division of Hematology, Department of Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.
出版信息
Adv Hematol. 2011;2011:427863. doi: 10.1155/2011/427863. Epub 2011 Dec 10.
Abstract
Mesenchymal stem cells (MSCs) represent a heterogeneous population of stromal cells with pluripotent mesenchymal differentiation potential. They have been found to have immunosuppressive properties and the ability to modulate angiogenesis and endogenous tissue repair by in vitro and animal studies. Clinical trials have examined the utility of these cells in autoimmune and inflammatory conditions. In particular, in allogeneic hematopoietic stem cell transplant (HSCT), multiple studies have been conducted to explore the use of MSC to treat acute and chronic graft-versus-host disease (GVHD) and for cotransplantation with HSCT to promote HSC engraftment and prevent GVHD. We review here the results of these studies and discuss some challenges of this treatment modality in this disease setting.
摘要
间充质干细胞（MSCs）是具有多能间充质分化潜能的异质性基质细胞群体。体外研究和动物研究发现，它们具有免疫抑制特性以及调节血管生成和内源性组织修复的能力。临床试验已对这些细胞在自身免疫性疾病和炎症性疾病中的效用进行了研究。特别是在异基因造血干细胞移植（HSCT）中，已经开展了多项研究来探索使用间充质干细胞治疗急性和慢性移植物抗宿主病（GVHD），以及与造血干细胞移植联合移植以促进造血干细胞植入并预防移植物抗宿主病。我们在此回顾这些研究结果，并讨论这种治疗方式在该疾病背景下所面临的一些挑战。
相似文献
1
Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease.间充质干细胞在移植物抗宿主病治疗与预防中的临床应用
Adv Hematol. 2011;2011:427863. doi: 10.1155/2011/427863. Epub 2011 Dec 10.
2
The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.间充质干细胞在造血干细胞移植中的作用：防治移植物抗宿主病。
Stem Cell Res Ther. 2019 Jun 21;10(1):182. doi: 10.1186/s13287-019-1287-9.
3
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.在血液系统恶性肿瘤患者中共同移植人类白细胞抗原（HLA）匹配的同胞培养扩增间充质干细胞和造血干细胞。
Biol Blood Marrow Transplant. 2005 May;11(5):389-98. doi: 10.1016/j.bbmt.2005.02.001.
4
Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.多能间充质基质细胞在异基因造血干细胞移植中的联合移植：一项系统评价和荟萃分析。
Cytotherapy. 2016 Feb;18(2):172-85. doi: 10.1016/j.jcyt.2015.11.010.
5
Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?间充质干细胞衍生的细胞外囊泡：在造血移植中发挥作用？
Int J Mol Sci. 2017 May 9;18(5):1022. doi: 10.3390/ijms18051022.
6
Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis.间充质基质细胞预防和治疗移植物抗宿主病的Meta 分析。
Stem Cell Res Ther. 2020 Feb 18;11(1):64. doi: 10.1186/s13287-020-01592-z.
7
Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.在白血病亲缘单倍体骨髓移植的体内模型中，间充质基质细胞预防移植物抗宿主病的效果降低。
Cell Transplant. 2013;22(8):1381-94. doi: 10.3727/096368912X657666. Epub 2012 Oct 4.
8
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.间充质干细胞共移植可能在非清髓性预处理 HLA mismatched 异基因移植后防止移植物抗宿主病 (GVHD) 导致的死亡，而不会消除移植物抗肿瘤效应。
Biol Blood Marrow Transplant. 2010 Jun;16(6):838-47. doi: 10.1016/j.bbmt.2010.01.011. Epub 2010 Jan 28.
9
Mesenchymal stromal cells and hematopoietic stem cell transplantation.间充质基质细胞与造血干细胞移植
Immunol Lett. 2015 Dec;168(2):215-21. doi: 10.1016/j.imlet.2015.06.013. Epub 2015 Jun 25.
10
Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?骨髓移植耐受：间充质基质细胞在急性或慢性移植物抗宿主病中仍有未来吗？
Front Immunol. 2020 Dec 11;11:609063. doi: 10.3389/fimmu.2020.609063. eCollection 2020.
引用本文的文献
1
Hybrid Micro-/Nanoprotein Platform Provides Endocrine-like and Extracellular Matrix-like Cell Delivery of Growth Factors.杂交微纳蛋白平台提供生长因子的类内分泌和细胞外基质样输送
ACS Appl Mater Interfaces. 2024 Jul 3;16(26):32930-32944. doi: 10.1021/acsami.4c01210. Epub 2024 Jun 18.
2
The protective mechanism of Klotho gene-modified bone marrow mesenchymal stem cells on acute kidney injury induced by rhabdomyolysis.Klotho基因修饰的骨髓间充质干细胞对横纹肌溶解症诱导的急性肾损伤的保护机制。
Regen Ther. 2021 Aug 13;18:255-267. doi: 10.1016/j.reth.2021.07.003. eCollection 2021 Dec.
3
Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries.针对深度且难以愈合的伤口，对细胞化人体组织工程皮肤替代品进行了研究。
NPJ Regen Med. 2021 Jun 17;6(1):35. doi: 10.1038/s41536-021-00144-0.
4
Xeno-Free Human Wharton's Jelly Mesenchymal Stromal Cells Maintain Their Characteristic Properties after Long-Term Cryopreservation.无动物源人脐带华通氏胶间充质基质细胞长期冷冻保存后仍保持其特性。
Cell J. 2021 Jul;23(2):145-153. doi: 10.22074/cellj.2021.7131. Epub 2021 May 26.
5
Current Advanced Therapies Based on Human Mesenchymal Stem Cells for Skin Diseases.基于人间充质干细胞的当前皮肤病先进疗法。
Front Cell Dev Biol. 2021 Mar 9;9:643125. doi: 10.3389/fcell.2021.643125. eCollection 2021.
6
Umbilical Cord-Derived Mesenchymal Stem Cells Are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications.脐带间充质干细胞能够利用 bFGF 治疗，代表了一种用于免疫抑制临床应用的极好工具。
Int J Mol Sci. 2020 Jul 28;21(15):5366. doi: 10.3390/ijms21155366.
7
Human umbilical cord-derived mesenchymal stem cells alleviate schizophrenia-relevant behaviors in amphetamine-sensitized mice by inhibiting neuroinflammation.人脐带间充质干细胞通过抑制神经炎症缓解安非他命敏化小鼠的精神分裂症相关行为。
Transl Psychiatry. 2020 Apr 27;10(1):123. doi: 10.1038/s41398-020-0802-1.
8
PTPN21 Overexpression Promotes Osteogenic and Adipogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells but Inhibits the Immunosuppressive Function.蛋白酪氨酸磷酸酶非受体型21过表达促进骨髓间充质干细胞的成骨和成脂分化，但抑制其免疫抑制功能。
Stem Cells Int. 2019 Nov 21;2019:4686132. doi: 10.1155/2019/4686132. eCollection 2019.
9
Light chain amyloidosis induced inflammatory changes in cardiomyocytes and adipose-derived mesenchymal stromal cells.轻链淀粉样变性引起心肌细胞和脂肪来源间充质基质细胞的炎症改变。
Leukemia. 2020 May;34(5):1383-1393. doi: 10.1038/s41375-019-0640-4. Epub 2019 Dec 3.
10
Canine Adipose-Derived Mesenchymal Stromal Cells Enhance Neuroregeneration in a Rat Model of Sciatic Nerve Crush Injury.犬脂肪间充质基质细胞增强大鼠坐骨神经挤压伤模型中的神经再生。
Cell Transplant. 2019 Jan;28(1):47-54. doi: 10.1177/0963689718809045. Epub 2018 Oct 28.
本文引用的文献
1
Concise review: Mesenchymal stem cell tumor-homing: detection methods in disease model systems.简明综述：间充质干细胞肿瘤归巢：疾病模型系统中的检测方法。
Stem Cells. 2011 Jun;29(6):920-7. doi: 10.1002/stem.645.
2
Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.体外用人血清扩增间充质干细胞治疗急性和慢性移植物抗宿主病的 I/II 期临床试验结果。
Haematologica. 2011 Jul;96(7):1072-6. doi: 10.3324/haematol.2010.038356. Epub 2011 Mar 10.
3
Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.同情使用研究中 ProchymalTM（体外培养的成人异体间充质干细胞）治疗儿童严重难治性急性移植物抗宿主病的疗效和安全性。
Biol Blood Marrow Transplant. 2011 Apr;17(4):534-41. doi: 10.1016/j.bbmt.2010.04.014. Epub 2010 May 8.
4
Mesenchymal stem cells as therapeutics.间充质干细胞治疗。
Annu Rev Biomed Eng. 2010 Aug 15;12:87-117. doi: 10.1146/annurev-bioeng-070909-105309.
5
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.间充质干细胞共移植可能在非清髓性预处理 HLA mismatched 异基因移植后防止移植物抗宿主病 (GVHD) 导致的死亡，而不会消除移植物抗肿瘤效应。
Biol Blood Marrow Transplant. 2010 Jun;16(6):838-47. doi: 10.1016/j.bbmt.2010.01.011. Epub 2010 Jan 28.
6
Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: a pilot study.单次动脉内注射间充质基质细胞治疗激素难治性急性移植物抗宿主病：一项初步研究。
Cytotherapy. 2010 Apr;12(2):265-8. doi: 10.3109/14653240903390795.
7
Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report.骨髓间充质干细胞治疗硬皮病样慢性移植物抗宿主病的疗效：临床报告。
Biol Blood Marrow Transplant. 2010 Mar;16(3):403-12. doi: 10.1016/j.bbmt.2009.11.006. Epub 2009 Nov 17.
8
Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells.人间充质干细胞与免疫抑制药物在同种异体反应中的相互作用：一项使用人类细胞的体外研究。
Transplant Proc. 2009 Oct;41(8):3347-52. doi: 10.1016/j.transproceed.2009.08.030.
9
Cotransplantation of HLA-identical mesenchymal stem cells and hematopoietic stem cells in Chinese patients with hematologic diseases.同种异体间充质干细胞与造血干细胞联合移植治疗血液系统疾病
Int J Lab Hematol. 2010 Apr;32(2):256-64. doi: 10.1111/j.1751-553X.2009.01181.x. Epub 2009 Jul 28.
10
Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.间充质干细胞输注与雷帕霉素协同作用可减弱同种异体免疫反应并促进心脏移植耐受。
Am J Transplant. 2009 Aug;9(8):1760-72. doi: 10.1111/j.1600-6143.2009.02721.x. Epub 2009 Jun 26.
Zotero 插件